Perceptive Advisors LLC Insider Trading Activity

Institutional Filer10%+ Owner ยท CIK 1224962

13

Total trades

$2.5M

Total volume

Nov 13, 2025

Last activity

LYRA

Lyra Therapeutics, Inc.

Perceptive Advisors LLC, an institutional filer, recorded 13 transactions over the last 12 months across 2 companies totaling $2.5M.

Activity concentrated in LYRA with 12 filings. The largest single transaction was a purchase of OBIO for $1.9M on Aug 1, 2025.

Performance Scorecard

Forward stock performance after each transaction by Perceptive Advisors LLC. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days-0.4%+11.3%77%13
90 days+45.8%+64.4%100%13
120 days+81.5%+70.3%100%13

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

๐Ÿ”’ Subscribe to see trade entries

Pro members see exactly when Perceptive Advisors LLC bought and sold LYRA.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEฮ” OWNEDROLEFILING
Nov 13, 2025
LYRASell28,597$3.90$112Kโˆ’18.6%10%+ Owner
Nov 13, 2025
LYRASell3,213$3.90$13Kโˆ’18.6%10%+ Owner
Nov 12, 2025
LYRASell7,862$4.06$32Kโˆ’4.9%10%+ Owner
Nov 12, 2025
LYRASell883$4.06$4Kโˆ’4.9%10%+ Owner
Nov 11, 2025
LYRASell4,783$4.31$21Kโˆ’2.9%10%+ Owner
Nov 11, 2025
LYRASell537$4.31$2Kโˆ’2.9%10%+ Owner
Nov 10, 2025
LYRASell16,633$4.54$76Kโˆ’9.1%10%+ Owner
Nov 10, 2025
LYRASell1,869$4.54$8Kโˆ’9.1%10%+ Owner
Nov 7, 2025
LYRASell17,746$4.75$84Kโˆ’8.9%10%+ Owner
Nov 7, 2025
LYRASell1,993$4.75$9Kโˆ’8.8%10%+ Owner
Nov 6, 2025
LYRASell28,902$5.18$150Kโˆ’12.6%10%+ Owner
Nov 6, 2025
LYRASell3,247$5.18$17Kโˆ’12.6%10%+ Owner
Aug 1, 2025
OBIOBuy700,000$2.75$1.9M+15.2%10%+ Owner

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
LYRALyra Therapeutics, Inc.12$527K
OBIOOrchestra BioMed Holdings, Inc.1$1.9M